Cabezón, M., Malinverni, R., Bargay, J., Xicoy, B., Marcé, S., Garrido Diaz, A., . . . Zamora, L. (2021). Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival.
Citación estilo ChicagoCabezón, Marta|||0000-0001-5122-7481, et al. Different Methylation Signatures At Diagnosis in Patients With High-risk Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia Predict Azacitidine Response and Longer Survival. 2021.
Cita MLACabezón, Marta|||0000-0001-5122-7481, et al. Different Methylation Signatures At Diagnosis in Patients With High-risk Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia Predict Azacitidine Response and Longer Survival. 2021.